Testing effectiveness (Phase 2)Study completedNCT02196324
What this trial is testing
Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
Who this might be right for
Prurigo Nodularis
Vyne Therapeutics Inc. 128